A gynecologic cancer researcher at Oita University in Japan has retracted three papers by his group after the discovery of duplicated figures and manipulated images.
The three papers by Noriyuki Takai and colleagues all appeared in Gynecologic Oncology: Continue reading Three gynecologic cancer studies retracted for figure duplication, image manipulation
Earlier today, we reported on what we thought was the first retraction to appear for Dirk Smeesters, who we noted was “the former Erasmus University social psychology professor investigated for serious irregularities in his work.” It turns out, however, as a Retraction Watch tipster told us, that another retraction had already been published.
The notice appeared in the August 2012 issue of the Journal of Consumer Research: Continue reading We missed one: Make that two retractions for Dirk Smeesters
A paper by Dirk Smeesters — the former Erasmus University social psychology professor investigated for serious irregularities in his work — has been retracted.
The study, “Visual perspective influences the use of metacognitive information in temporal comparisons,” appeared in the Journal of Personality and Social Psychology earlier this year. Here’s the notice, which doesn’t quite say “fraud”: Continue reading Retraction appears for paper by social psychologist Dirk Smeesters
The Dutch media are reporting that Diederik Stapel, the Tilburg University social psychologist who fabricated data in dozens of studies, is facing a criminal probe for his misuse of some 2.2 million euros (roughly $2.8 million U.S.) in government grant funding.
A Retraction Watch commenter tipped us off this morning that the newspaper NRC Handelsblad reports (thanks to Google Translate): Continue reading Diederik Stapel faces criminal inquiry for misuse of funds
We couldn’t help noticing that the past few weeks have seen calls to retract two papers on food, from different sides of the political spectrum. One paper actually looked at the effects of genetically modified organisms (GMOs), while the GMO link in the other paper seems mostly to be in activists’ minds. Consider:
On the right, we have Henry I. Miller writing on Forbes.com about a study of rats fed genetically modified maize: “The honorable course of action for the journal would be to retract the paper immediately“: Continue reading Left and right apparently agree that “GMO” studies should be retracted (but they’re talking about different papers)
A group of researchers from Austria, Canada, Germany, and the U.S. have retracted a 2008 paper in the Journal of Immunology after being unable to verify the contents of some key figures.
Here’s the notice: Continue reading Immunology paper retracted because “documents were not archived with due diligence”
Michael Hertl, a leading dermatology researcher at Philipps-University Marburg, has been cleared of any wrongdoing in a case that spawned a retraction last year and two just-published retractions.
Felicitas Riedel, a legal officer for the university, tells Retraction Watch that the
…Committee for Scientific Misconduct of the Philipps-University Marburg closed the matter and submitted its results to the President of the University who in the meantime after examination consented with it.
The findings? Continue reading University clears leading dermatology lab head of misconduct as authors issue two corrections
The World Journal of Surgical Oncology has posted the retraction of a 2010 article by Italian researchers who lifted substantial parts of their text from a group that had published on the same topic seven years earlier.
The article, “Colon and rectal surgery for cancer without mechanical bowel preparation: one-center randomized prospective trial,” came from a group of surgical oncologists at San Martino Hospital in Genoa led by Stefano Scabini, who is listed in other publications as chief of the service.
According to the notice: Continue reading Authors retract “one-center” cancer study for plagiarizing from…another center
A group of researchers from Texas and Zimbabwe has lost a paper after they tried publishing it twice — first in the European Journal of Clinical Pharmacology, and then in the International Journal of Clinical Pharmacy.
Here’s the notice: Continue reading Study linking antidepressants to diabetes retracted when authors publish it twice
Perhaps fittingly in today’s age of sensitive feelings, the typical reaction to a retraction (per the notices, at least) is apology. But bliss?
Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” by Dieletta Bianchini. Turns out the authors had published the same (or nearly so) paper two months earlier in a different journal. Here’s the notice: Continue reading Retraction for prostate cancer paper duplication leaves authors penitent, “happy”